Journal of Thoracic Oncology

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Journal of Thoracic Oncology
Jun 21, 2025, 15:24 | Science
Stephen V Liu: Surgical Outcomes from AEGEAN Are Published in the Journal of Thoracic Oncology
Stephen V Liu, Director of Thoracic Oncology and Associate Professor of Medicine at Georgetown University,…
Jun 21, 2025, 14:31 | Blog
JTO and JTO CRR Achieve Strong Impact Factors in Oncology and Respiratory Medicine - IASLC
International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn: "We're…
Jun 17, 2025, 06:18 | Insight
Aakash Desai Shared A Study Published In JTO on Datopotamab Deruxtecan In Patients With EGFR-mutated NSCLC
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at…
Jun 2, 2025, 12:33 | Blog
Alex Adjei is selected as the President Elect of International Association for the Study of Lung Cancer
Jame Abraham, Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic and a…
May 11, 2025, 13:57 | Science
Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
May 9, 2025, 15:02 | Science
Aakash Desai: New insights in BRAFV600–mutated NSCLC
Aakash Desai, Assistant Professor and Associate Director of Phase 1 and Precision Oncology Program at the…
Mar 6, 2025, 18:38 | Insight
Vun-Sin Lim: 10 Most Cited 2024 Articles in the Journal of Thoracic Oncology
Vun-Sin Lim, Managing Editor of the Journal of Thoracic Oncology, shared a post on LinkedIn:…
Feb 6, 2025, 16:34 | Blog
Elsevier Oncology's special article collection dedicated to World Cancer Day
Elsevier Oncology shared a post on LinkedIn: "To mark World Cancer Day, we're proud to…
Jan 25, 2025, 03:46 | Insight
Estela Rodriguez: Using nivolumab plus ipilimumab as a treatment to patients with metastatic NSCLC
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group…
Jan 13, 2025, 13:19 | Insight
Dipesh Uprety: Our article on adjuvant IO after pCR in Patients With Non-Small Cell Carcinoma
Dipesh Uprety, Assistant Professor of Thoracic Oncology at the Barbara Ann Karmanos Cancer Institute, shared…
Jan 3, 2025, 16:25 | Science
Amivantamab Plus Lazertinib in Patients With EGFR-mutant NSCLC by Benjamin Besse et al.
A recent article by Benjamin Besse et al. was mentioned by Akhil Santhosh, Medical Oncology Specialist at…
Dec 22, 2024, 04:40 | Science
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.
A recent paper by So Yeon Kim, Assistant Professor in Pulmonary and Critical Care Medicine…
Nov 18, 2024, 17:34 | Blog
Evaluating the clinical value of a tumor-naïve, methylation-based cell-free DNA assay in resected NSCLC - IASLC
IASLC posted on X about recent paper by Tae Hee Hong et al., titled "Clinical…
Nov 3, 2024, 16:27 | Insight
Alessandro Di Federico: EFS in patients with resectable NSCLC treated with neoadjuvant Chemo-IO
Alessandro Di Federico, Medical Oncologist and Ph.D. student at the University of Bologna, shared a…
Oct 31, 2024, 09:03 | Insight
Jarushka Naidoo: Maintenance Pembrolizumab with or without Olaparib for Advanced Squamous NSCLC
Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin, shared a post on X about…
Oct 20, 2024, 17:47 | Drugs
Stephen V Liu: Long-term survival with nivolumab and ipilimumab in advanced NSCLC
Stephen V Liu shared on X: "Long-term survival (median f/u 73.7m) with nivolumab and ipilimumab…
Oct 7, 2024, 16:22 | Insight
Xiuning Le: Mutational characteristics and clinical outcomes for EGFR+ lung adenocarcinoma
Xiuning Le, Associate Professor of Thoracic Head and Neck Medical Oncology at the MD Anderson…
Sep 14, 2024, 15:07 | Blog
Ivy Riano: The JTO Reviewer Workshop WCLC24
Ivy Riano posted on X: "Thank you so much Journal of Thoracic Oncology, IASLC for…
Aug 6, 2024, 11:29 | Insight
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers
Lung-MAP shared on LinkedIn: "Just out in Journal of Thoracic Oncology (JTO): Lung-MAP Next Generation…
Jul 18, 2024, 11:08 | Blog
Stephen V Liu: Retrospective study looks at immunotherapy in patients with NSCLC and autoimmune condition
Stephen V Liu shared on X: "Retrospective NEJ047 study looks at immunotherapy in patients with NSCLC…
Jul 5, 2024, 06:54 | Blog
Estela Rodriguez: Underreported toxicity of myopathy from EGFR TKIs
Estela Rodriguez shared a post by Stephen V Liu, on X: "Important to study under reported toxicity…
Jun 26, 2024, 14:53 | Blog
Patrick Forde: Consensus recommendations from IASLC for lung cancer
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies at Sidney Kimmel Comprehensive Cancer Center,…
May 13, 2024, 14:29 | Insight
Jarushka Naidoo: A step forward in implementing anti-PD(L)1 across growing not otherwise specified of indications?
Jarushka Naidoo shared on X: "Ph III IMscin001 trial of Subcutaneous (sc) vs IV Atezolizumab…
Nov 28, 2023, 18:00 | Drugs
Stephen V Liu: Report on real world efficacy and safety of amivantamab including off label use
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at the Lombardi Comprehensive Cancer…
Sep 27, 2023, 18:18 | Insight
Aakash Desai: Out in Journal of Thoracic Oncology our editorial “Toxicity From Sotorasib after ICI: A Note of Caution and Reflections of Future Advancements in the Field”.
All: 25 Posts: 1 - 100
Special Coverage